Outset Medical, Inc. (OM)

3,1400 +0,1400 (+4,67%) Börsenschluss: 04:00PM EDT

Outset Medical, Inc.

3052 Orchard Drive
San Jose, CA 95134
United States
669 231 8200
https://www.outsetmedical.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 480

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Leslie L. Trigg	President, CEO & Chairman	1,22M	3,56M	1971
Mr. Nabeel Ahmed	Chief Financial Officer	613,33k	N/A	1976
Mr. Jean-Oliver Racine	Chief Technology Officer	528,95k	N/A	1982
Mr. John L. Brottem	General Counsel & Secretary	547,1k	152,21k	1975
Mr. Marc Nash	Senior Vice President of Operations and R&D	N/A	N/A	1989
Mr. James S. Mazzola	Head of Investor Relations	N/A	N/A	N/A
Nicole Shannon	Director of Marketing Communications	N/A	N/A	N/A
Dr. Michael Aragon M.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Mark Gordon M.S.	Chief Regulatory & Quality Officer	N/A	N/A	1957

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Corporate Governance

Outset Medical, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 8. Die grundlegenden Scores sind Audit: 9, Vorstand: 7, Shareholderrechte: 8, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.